Holds one active US DMF and one valid CEP for glimepiride, filing since 2003. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.
Holds one active US DMF and 2 valid CEPs for glimepiride, filing since 2006. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds one active US DMF and 2 valid CEPs for glimepiride, filing since 2022. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 20 markets.
Holds one active US DMF and 2 valid CEPs for glimepiride, filing since 2003. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 9 markets.
Holds one active US DMF and one valid CEP for glimepiride, filing since 2021. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds 2 active US DMFs and 2 valid CEPs for glimepiride, filing since 2004. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for glimepiride, filing since 2004. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds one active US DMF and one valid CEP for glimepiride, filing since 2024. Its 2024 FDA inspection closed as VAI.
This page filters the worldwide Glimepiride manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for glimepiride and what filings they hold.
Chat with Fred, your AI analyst